What can be done to improve oocyte (egg) quality in a woman seeking pregnancy or IVF?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Improving Oocyte Quality for Pregnancy and IVF

For women seeking pregnancy or undergoing IVF, adopt a Mediterranean diet and consider targeted supplementation with CoQ10 (for poor ovarian response or advanced age), omega-3 fatty acids (for egg quality), and vitamin D combined with probiotics (for pregnancy rates), while prioritizing evidence-based fertility treatments over unproven therapies. 1, 2, 3

Dietary Interventions

Adopt a Mediterranean diet as the foundational nutritional approach. 2 This represents the simplest, most evidence-based dietary modification for women pursuing fertility treatment.

  • Omega-3 fatty acid supplementation improves oocyte quality and may prolong reproductive function, even when initiated during the age-related decline in fertility 2, 4
  • Omega-3 supplementation may lead to improvements in both clinical and embryological IVF outcomes 2
  • Conversely, diets rich in omega-6 fatty acids are associated with poor reproductive success and oocyte quality at advanced maternal age 4

Targeted Supplementation Based on Clinical Scenario

For Poor Ovarian Response or Advanced Maternal Age

Start DHEA and CoQ10 before cycle commencement rather than waiting until stimulation begins 2:

  • CoQ10 supplementation increases clinical pregnancy rates (OR 2.49) in women undergoing IVF, though optimal patient selection (older women vs. poor responders vs. poor embryo development) remains unclear 2, 5
  • CoQ10 may be particularly beneficial for women with diminished ovarian reserve or advanced age 2
  • DHEA shows benefit for poor ovarian response, though the evidence quality is limited 2

For Women with PCOS

Myo-inositol supplementation increases clinical pregnancy rates (RR 1.52) in women with PCOS, though optimal dosing remains undefined 2, 5:

  • Clomiphene citrate 50-150 mg/day for 5 days remains first-line for anovulatory PCOS patients, inducing ovulation in 70% with 44% pregnancy rates within three cycles 1
  • Myo-inositol serves as an adjunctive therapy to standard ovulation induction 2, 5

For All Women Undergoing IVF

Consider these evidence-supported supplements:

  • Melatonin may improve IVF outcomes, though the specific patient population most likely to benefit and optimal dosing require clarification 2, 5
  • Vitamin D combined with probiotics shows the most significant increase in clinical pregnancy rates (RR 1.29) compared to alternative interventions 3
  • Multiple micronutrients and antioxidants increase live birth rates (OR 2.59 and 1.81 respectively) in women utilizing MAR, though evidence certainty is very low 5
  • Curcumin alone demonstrates substantial increases in oocytes retrieved (MD 6.96) and fertilization rates (MD 9.02), though evidence certainty is very low 3
  • Astaxanthin increases the number of good-quality embryos (MD 1.17), though evidence certainty is very low 3

Ovarian Stimulation Optimization

Controlled ovarian stimulation with gonadotropins remains the gold standard for routine fertility preservation and IVF 1:

  • Random-start stimulation protocols can be initiated at any menstrual cycle point and completed rapidly (within 2 weeks) when time-sensitive 1
  • For breast cancer patients, letrozole or tamoxifen combined with gonadotropins achieves adequate oocyte yield while maintaining lower estradiol levels 1

In vitro maturation (IVM) represents an important alternative for urgent cases or repeated poor response:

  • IVM achieves 59.7% oocyte maturation rates with comparable fertilization and embryo development to standard protocols 1
  • OTO-IVM combined with ovarian tissue cryopreservation yields a mean of 11.27 oocytes per patient 1
  • IVM is particularly valuable when time before gonadotoxic treatments is limited 1

Critical Pitfalls to Avoid

Do not delay evidence-based treatments in favor of unproven therapies such as acupuncture, which lacks high-quality evidence for treating infertility 1:

  • Delaying proven treatments may reduce conception chances, especially for women of advanced maternal age 1
  • Direct patients to evidence-based interventions including IVF, ICSI, and IUI 1

Avoid testosterone therapy, which is absolutely contraindicated in women seeking fertility as it suppresses ovulation 6

Do not rely on GnRH agonists during chemotherapy for fertility preservation, as they do not reliably preserve fertility despite some improvement in menstrual recovery 1, 6:

  • Meta-analyses show inconsistent results, with some benefit for breast cancer patients but not for lymphoma patients 6
  • The quality of evidence is relatively low with significant heterogeneity 6

Understanding Age and Ovarian Reserve

Age is a more significant factor than AMH in young patients 1:

  • AMH fluctuates significantly throughout the menstrual cycle in women under 25 years 1
  • Low AMH indicates reduced but not absent follicle pool and does not preclude pregnancy 1
  • In women under 25 years, interpret AMH cautiously and perform baseline FSH and estradiol assessment to rule out premature ovarian insufficiency 1

Deterioration of oocyte quality with increasing maternal age is a primary cause of female infertility, accounting for a significant proportion of fertility decline 6

Safety Considerations

Current evidence shows no significant harm from nutrient supplementation:

  • NAC, vitamin D, and pooled antioxidants have no effect on miscarriage rates or multiple pregnancy rates with low to very low certainty evidence 5
  • Pooled antioxidants have no effect on ectopic pregnancy rates with low certainty evidence 5
  • No interventions are significantly linked to miscarriage 3

Evidence Quality Context

The available evidence for nutrient supplementation is predominantly very low to low certainty, with most recommendations based on small studies and meta-analyses with significant heterogeneity 5. However, given the lack of significant harm and potential benefits, supplementation represents a reasonable adjunctive approach to standard fertility treatments 2, 3, 5. The priority remains evidence-based fertility treatments (IVF, ovulation induction) rather than supplements alone 1.

Related Questions

What are the potential interactions and recommended dosages for ovarian care ingredients with supplements like Selective Serotonin Reuptake Inhibitors (SSRI), Docosahexaenoic acid (DHA), vitamin D, prenatal vitamin, Vitamin C, N-acetylcysteine (NAC), and vitamin K2?
Is it safe for a female of reproductive age undergoing egg retrieval as part of fertility treatment to take magnesium threonate?
Does Mucinex (Guaifenesin) improve fertility in females?
What foods and medications should be avoided during in vitro fertilization (IVF) stimulation?
Are dietary supplements recommended for individuals of childbearing age planning to form a family?
In a female patient with autism spectrum disorder, ADHD, and comorbid anxiety‑depressive syndrome who is taking venlafaxine 75 mg daily and escitalopram 10 mg daily, what is the safest order and timing to add lisdexamfetamine 30 mg?
Can I dispatch an ambulance to an adult patient’s home who is mentally competent and voluntarily refusing transport to the emergency department?
What is the recommended timing for taking escitalopram, venlafaxine, and lisdexamfetamine—can escitalopram be taken at night and venlafaxine together with lisdexamfetamine in the morning?
What is the recommended management of flexor tenosynovitis following a dog bite?
What is the recommended management for a sexual partner diagnosed with early syphilis, including treatment regimen, testing, follow‑up, and considerations for penicillin allergy, pregnancy, and HIV co‑infection?
What evidence‑based interventions can be used to increase positive affect in a 34‑year‑old woman with chronic major depressive disorder, currently on aripiprazole (Abilify) and escitalopram (Lexapro), with a history of childhood trauma, ongoing gambling and methamphetamine misuse, and an unfulfilling same‑sex relationship?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.